IL48697A - 1,3,7-trisubstituted xanthine derivatives,their preparatioand pharmaceutical compositions containing them - Google Patents

1,3,7-trisubstituted xanthine derivatives,their preparatioand pharmaceutical compositions containing them

Info

Publication number
IL48697A
IL48697A IL48697A IL4869775A IL48697A IL 48697 A IL48697 A IL 48697A IL 48697 A IL48697 A IL 48697A IL 4869775 A IL4869775 A IL 4869775A IL 48697 A IL48697 A IL 48697A
Authority
IL
Israel
Prior art keywords
preparatioand
pharmaceutical compositions
compositions containing
xanthine derivatives
trisubstituted xanthine
Prior art date
Application number
IL48697A
Other languages
English (en)
Other versions
IL48697A0 (en
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of IL48697A0 publication Critical patent/IL48697A0/xx
Publication of IL48697A publication Critical patent/IL48697A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL48697A 1974-12-21 1975-12-19 1,3,7-trisubstituted xanthine derivatives,their preparatioand pharmaceutical compositions containing them IL48697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (2)

Publication Number Publication Date
IL48697A0 IL48697A0 (en) 1976-02-29
IL48697A true IL48697A (en) 1979-07-25

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48697A IL48697A (en) 1974-12-21 1975-12-19 1,3,7-trisubstituted xanthine derivatives,their preparatioand pharmaceutical compositions containing them

Country Status (31)

Country Link
US (1) US3998953A (fr)
JP (1) JPS5188995A (fr)
AT (1) AT341540B (fr)
AU (1) AU501889B2 (fr)
BE (1) BE836898A (fr)
BG (1) BG25518A3 (fr)
CA (1) CA1036159A (fr)
CH (1) CH628346A5 (fr)
CS (1) CS191289B2 (fr)
DD (1) DD124984A5 (fr)
DE (1) DE2460929A1 (fr)
DK (1) DK137677C (fr)
ES (2) ES443738A1 (fr)
FI (1) FI62089C (fr)
FR (1) FR2294706A1 (fr)
GB (1) GB1517710A (fr)
GR (1) GR59204B (fr)
HU (1) HU174673B (fr)
IE (1) IE43208B1 (fr)
IL (1) IL48697A (fr)
LU (1) LU73972A1 (fr)
NL (1) NL7514837A (fr)
NO (1) NO144928C (fr)
NZ (1) NZ179599A (fr)
PH (1) PH11810A (fr)
PL (1) PL99165B1 (fr)
RO (1) RO68381A (fr)
SE (1) SE420493B (fr)
SU (1) SU603340A3 (fr)
YU (1) YU39004B (fr)
ZA (1) ZA757865B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (fr) * 1997-12-17 1999-06-24 University Of South Florida Antagonistes du recepteur de l'adenosine presentant une bioactivite amelioree
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (fr) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (fr) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
AU8754775A (en) 1977-06-23
DK571875A (da) 1976-06-22
FI62089C (fi) 1982-11-10
ATA904575A (de) 1977-06-15
GR59204B (en) 1977-11-26
CA1036159A (fr) 1978-08-08
NZ179599A (en) 1978-03-06
FR2294706A1 (fr) 1976-07-16
IL48697A0 (en) 1976-02-29
CH628346A5 (de) 1982-02-26
HU174673B (hu) 1980-03-28
YU39004B (en) 1983-12-31
DD124984A5 (fr) 1977-03-23
RO68381A (fr) 1982-02-26
SE7514477L (sv) 1976-06-22
US3998953A (en) 1976-12-21
ES443738A1 (es) 1977-04-16
PH11810A (en) 1978-07-10
BE836898A (fr) 1976-06-21
BG25518A3 (en) 1978-10-10
ZA757865B (en) 1977-08-31
DK137677C (da) 1978-09-25
DK137677B (da) 1978-04-17
IE43208B1 (en) 1981-01-14
LU73972A1 (fr) 1977-02-15
IE43208L (en) 1976-06-21
SE420493B (sv) 1981-10-12
SU603340A3 (ru) 1978-04-15
NL7514837A (nl) 1976-06-23
FR2294706B1 (fr) 1978-12-01
AT341540B (de) 1978-02-10
NO144928B (no) 1981-08-31
DE2460929C2 (fr) 1987-12-17
FI62089B (fi) 1982-07-30
PL99165B1 (pl) 1978-06-30
AU501889B2 (en) 1979-07-05
NO754317L (fr) 1976-06-22
DE2460929A1 (de) 1976-06-24
FI753543A (fr) 1976-06-22
JPS5188995A (fr) 1976-08-04
YU323475A (en) 1982-08-31
GB1517710A (en) 1978-07-12
CS191289B2 (en) 1979-06-29
ES451457A1 (es) 1977-10-01
NO144928C (no) 1981-12-09

Similar Documents

Publication Publication Date Title
ZA743760B (en) Xanthine derivatives
IL47625A (en) 4-heterocyclyl-6,7-dialkoxyquin-azoline derivatives and pharmaceutical compositions containing them
IL46760A (en) 2-tetrahydrofurfuryl-6,7-benzomorphane derivatives,their production and pharmaceutical compositions containing them
IL48069A (en) Imidazo-(1,5-a)(1,4)-diazepine derivatives, their preparation and pharmaceutical compositions containing them
IL47877A0 (en) Novel thienothiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL48502A (en) Tthieno(1,5)benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
IL47735A0 (en) Novel ergoline i derivatives,their production and pharmaceutical compositions containing them
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
IL48697A (en) 1,3,7-trisubstituted xanthine derivatives,their preparatioand pharmaceutical compositions containing them
IL49280A (en) Pharmaceutical compositions containing substituted o-hydroxy-benzophenone derivatives
IL47878A (en) S-substituted 4,5-diphenyloxazole-2-thiol derivatives,their preparation and compositions containing them
ZA742956B (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
IL46809A0 (en) Ergoline derivatives,their production and pharmaceutical compositions containing them
IL46957A0 (en) Novel theophylline derivatives,their preparation and pharmaceutical compositions containing them
HK17281A (en) Pharmaceutical compositions
GB1555991A (en) Pharmaceutical compositions containing adenosine derivatives
IL48183A0 (en) New cephalosporin derivatives,processes for their preparation and pharmaceutical compositions containing them
IL48098A0 (en) Pharmaceutical compositions containing diphenylethanol derivatives
IL49747A (en) 2-amino-4-phenylimidazoline derivatives, their preparationand pharmaceutical compositions containing them
IL48230A0 (en) Pharmaceutical compositions containing 2-naphthyl-butyric acid derivatives
ZA757303B (en) Xanthine derivatives
IL47474A0 (en) New triazole derivatives,their production and pharmaceutical compositions containing them
IL48208A (en) L -fluoro-21-hydroxy-16 -methyl- 1,4,8-pregnatriene derivatives,process for their preparation and pharmaceutical compositions containing them
IL47192A (en) 5,7-dihydro-5,5,7,7-tetramethyl-3-phenylfuro(3,4-e)-as-triazine derivatives their preparation and pharmaceutical compositions containing them
IL48603A0 (en) Hexahydroindolinol derivatives,their production and pharmaceutical compositions containing them